Jane Street Group, LLC Tiziana Life Sciences LTD Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$0.65 - $1.29 $8,431 - $16,732
12,971 New
12,971 $8,000
Q3 2022

Nov 14, 2022
BUY
$0.55 - $0.83 $5,576 - $8,415
10,139 New
10,139 $8,000
Q1 2022

May 17, 2022
SELL
$0.62 - $1.25 $30,652 - $61,798
-49,439 Closed
0 $0
Q4 2021

Feb 15, 2022
BUY
$0.89 - $1.66 $44,000 - $82,068
49,439 New
49,439 $47,000

Others Institutions Holding TLSA

# of Institutions
31
Shares Held
1.03M
Call Options Held
19.2K
Put Options Held
0
View Full List

About Tiziana Life Sciences Ltd

TLSA Quotes by TradingView
  • Ticker TLSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,273,000
  • Market Cap $91M
  • Description
  • Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...
More about TLSA
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email